01
Dr. Reddy’s announces ANDA approval of Omeprazole Mg OTC
02
Our Purpose:
Providing Affordable &
Innovative medicines for healthier
lives
04
Product Portfolio:
Active Pharmaceutical Ingredients (APIs)
- Among the Top-3 API player globally
- 140 APIs in the market
- 20 products under development at any given point of time
06
Product Portfolio:
Proprietary Products
Generic Biopharmaceuticals
- 2 products in the market: GrafeelTM (generic Filgrastim) & RedituxTM, (generic Rituximab)
- 8 products in pipeline
Promius Pharma
- 2 products in the market: EpiCeram® Skin Barrier Emulsion and Scytera® Foam
08
First manufacturing company
from India to be SOX certified
09
Our businesses employs
about 11000 associates globally
11
We are the first Asia Pacific pharmaceutical
company, outside Japan, to list on the
New York Stock Exchange.
12
We are the fastest
Indian Pharma company to cross
$1 billion in revenues.
13
Acquired betapharm - the fourth-largest generics company in Germany in 2006.
It was the largest overseas acquisition ever by an Indian company at that point of time.
